Skip to main content
MMSI logo

Merit Medical Systems, Inc.

MMSINASDAQHealthcareMedical Instruments & Supplies

$89.20Today:- (-)1Y +9.41%

As of Oct 16, 2026 close

Market cap
$5.37B
P/E (TTM)
36.92
Forward P/E
30.21
Dividend yield
-
52-week range
$59.74$94.75
Volume (live)
-
Avg. volume (3M)
612.60K

Merit Medical Systems (MMSI) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Merit Medical Systems generated $297.37M of operating cash flow and spent $81.72M on capital expenditures. That left free cash flow of $215.66M, up 18.0% from $182.76M a year earlier, or 14.2% of revenue.

Merit Medical Systems Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Merit Medical Systems, Inc. (MMSI) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income128.49120.3694.4174.5248.45-9.845.4542.0227.52
Depreciation & Amortization123.17114.7389.9981.8095.78106.82104.3669.5553.58
Deferred Income Tax5.21-14.87-12.64-14.92-4.63-11.30-12.442.05-1.30
Stock Based Compensation43.4628.4721.3318.0416.0914.349.386.124.08
Change in Working Capital-23.34-36.95-70.02-71.40-17.8434.24-55.73-35.94-24.20
Change in Accounts Receivable-2.97-21.70-9.49-10.96-8.6210.43-17.90-27.52-12.84
Change in Inventory-21.60-2.29-32.11-47.93-25.1829.43-27.04-28.17-17.83
Change in Accounts Payable1.01-4.10-7.3012.665.930.33-2.3015.730.42
Change in Other Working Capital-19.357.11-16.96-13.273.66-4.79-8.494.026.06
Other Operating Activities25.607.119.4411.333.66-19.3926.792.753.05
Net Cash from Operating Activities297.37220.80145.15114.29147.23165.2777.8186.5362.73
Investing Activities
Capital Expenditures-81.72-38.04-34.29-45.03-30.77-45.99-81.50-66.34-41.20
Acquisitions-144.77-320.18-134.52-6.88-7.17-10.95-53.90-301.79-105.58
Sales/Maturities of Investments0.000.00-2.41-3.180.00-3.290.000.000.00
Other Investing Activities-18.08-48.47-4.76-1.41-2.050.250.92-10.700.02
Net Cash from Investing Activities-247.39-368.65-175.35-57.40-37.16-58.65-134.48-378.82-146.76
Financing Activities
Debt Repayment0.00-99.06-579.62-260.14-206.92-88.3844.50116.50-46.42
Common Stock Issued28.2140.9115.5820.0721.316.646.25214.99143.81
Common Stock Repurchased0.000.00-5.12-2.470.00-0.870.000.000.00
Other Financing Activities-2.69-1.85-70.77-32.92-11.24-13.10-17.22-3.21-0.88
Net Cash from Financing Activities16.00-60.01559.27-60.26-98.44-95.7133.53328.2896.52
Summary
Effect of Forex Changes on Cash3.80-2.52-0.48-3.83-0.801.680.10-0.970.68
Net Change in Cash69.78-210.38528.59-7.1911.6412.60-23.0435.0213.17
Cash at Beginning of Period378.77589.1460.5667.7556.9244.3267.3632.3419.17
Cash at End of Period448.55378.77589.1460.5667.7556.9244.3267.3632.34
Free Cash Flow215.66182.76110.8669.26116.46119.28-3.6820.2021.53
Supplemental Disclosures
Interest Paid-23.2414.056.265.2610.08---
Income Taxes Paid-45.0531.5317.098.838.92---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Merit Medical Systems Cash Flow

What is Merit Medical Systems's free cash flow?

Merit Medical Systems generated free cash flow of $215.66M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $297.37M minus $81.72M of capital expenditures. That was up 18.0% from $182.76M a year earlier. Free cash flow equaled 14.2% of revenue.

How much does Merit Medical Systems spend on capital expenditures?

Merit Medical Systems spent $81.72M on capital expenditures in fiscal 2025, compared with $38.04M a year earlier. That equals 27.5% of operating cash flow.

Does Merit Medical Systems pay dividends or buy back shares?

Merit Medical Systems's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition